Progyny (PGNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research on MSN
Take the Zacks approach to beat the markets: Liquidia, Western Digital & Johnson & Johnson in focus
The U.S. stock markets ended the week mostly lower, with the tech-heavy Nasdaq Composite and the S&P 500 slipping by 1.49% ...
Zacks Investment Research on MSN
Surging earnings estimates signal upside for Synopsys (SNPS) stock
Synopsys (SNPS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates.
The Tech sector has been driving aggregate earnings growth since 2023 Q3, and the trend is expected to continue in 2025 Q4 and beyond. For Q4, Tech sector earnings are expected to be up +13% from the ...
Zacks.com on MSN
The Best AI Stocks to Buy for 2026 (LITE, COHR, FN)
Against this backdrop, Lumentum ( LITE ), Coherent Corp ( COHR ), and Fabrinet ( FN) occupy strategically important segments ...
Amicus jumped to a new 52-week high on Friday, as investors took heart from an investment firm’s optimistic coverage and ...
BROOKLYN, N.Y. (AP) — BROOKLYN, N.Y. (AP) — J.W. Mays Inc. (MAYS) on Thursday reported a loss of $334,000 in its fiscal first ...
Netskope expects full-year results to range from a loss of 53 cents per share to a loss of 51 cents per share, with revenue ranging from $701 million to $703 million.
HANOVER, Md. (AP) — HANOVER, Md. (AP) — Ciena Corp. (CIEN) on Thursday reported fiscal fourth-quarter profit of $19.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results